Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel antibodies designed by researchers in Cuba and Uruguay

Aug. 3, 2012

Novel DLL4-directed antibodies reported

Aug. 3, 2012

Agios Pharmaceuticals divulges novel PKM2 activators

Aug. 3, 2012

New phase I-II data disclosed on renal cell carcinoma vaccine candidate

Aug. 3, 2012

Curagenix synthesizes new inhibitors of Wnt signaling

Aug. 3, 2012

Lixte Biotechnology's lead anticancer agent clear to enter clinic

Aug. 2, 2012

Novel paclitaxel prodrugs synthesized in U.S.

Aug. 2, 2012

Dabrafenib improves progression-free survival in phase III trial

Aug. 2, 2012

Phase II study confirms efficacy of carfilzomib in multiple myeloma

Aug. 2, 2012

Novotyr Therapeutics designs novel IGF-I receptor inhibitors

Aug. 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...